{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:09:09Z","timestamp":1790996949258,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014039","name":"DOD Prostate Cancer Research Program","doi-asserted-by":"publisher","award":["W81XWH-15-1-0558"],"award-info":[{"award-number":["W81XWH-15-1-0558"]}],"id":[{"id":"10.13039\/100014039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014039","name":"DOD Prostate Cancer Research Program","doi-asserted-by":"publisher","award":["W81XWH-20-1-0851"],"award-info":[{"award-number":["W81XWH-20-1-0851"]}],"id":[{"id":"10.13039\/100014039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL158071"],"award-info":[{"award-number":["R01HL158071"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL15127701A1"],"award-info":[{"award-number":["1R01HL15127701A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["C06 RR12463-01"],"award-info":[{"award-number":["C06 RR12463-01"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["IBX004121A"],"award-info":[{"award-number":["IBX004121A"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["1R43EB028736-01"],"award-info":[{"award-number":["1R43EB028736-01"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018313","name":"Cleveland Eye Bank Foundation","doi-asserted-by":"publisher","award":["K23-EY022947-01A1"],"award-info":[{"award-number":["K23-EY022947-01A1"]}],"id":[{"id":"10.13039\/100018313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA208236-01A1"],"award-info":[{"award-number":["R01CA208236-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA220581-01A1"],"award-info":[{"award-number":["R01CA220581-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA216579-01A1"],"award-info":[{"award-number":["R01CA216579-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA26820701A1"],"award-info":[{"award-number":["R01CA26820701A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA257612-01A1"],"award-info":[{"award-number":["R01CA257612-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA248226"],"award-info":[{"award-number":["U01CA248226"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA239055"],"award-info":[{"award-number":["U01CA239055"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA254566"],"award-info":[{"award-number":["U54CA254566"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA249992"],"award-info":[{"award-number":["R01CA249992"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA202752"],"award-info":[{"award-number":["R01CA202752"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA268287A1"],"award-info":[{"award-number":["R01CA268287A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA269181"],"award-info":[{"award-number":["U01CA269181"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e32232","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T20:47:11Z","timestamp":1718311631000},"page":"e32232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Optical coherence tomography-derived texture-based radiomics features identify eyes with intraocular inflammation in the HAWK clinical trial"],"prefix":"10.1016","volume":"10","author":[{"given":"Sudeshna","family":"Sil Kar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Madabhushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6763-7768","authenticated-orcid":false,"given":"Justis P.","family":"Ehlers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e32232_bib1","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1038\/s41598-022-07108-4","article-title":"Neovascular age-related macular degeneration in which exudation predominantly occurs as a subretinal fluid during anti-vascular endothelial growth factor treatment","volume":"12","author":"Cho","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e32232_bib2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2147\/OPTH.S231913","article-title":"Neovascular age-related macular degeneration (nAMD): a review of emerging treatment options","volume":"16","author":"Tan","year":"2022","journal-title":"Clin. Ophthalmol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e32232_bib3","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ophtha.2020.11.011","article-title":"Risk of inflammation, retinal vasculitis, and retinal occlusion-related events with brolucizumab: post hoc review of HAWK and HARRIER","volume":"128","author":"Mon\u00e9s","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.heliyon.2024.e32232_bib4","article-title":"A real-world study assessing the impact of retinal fluid on visual acuity outcomes in patients with neovascular age-related macular degeneration in Korea","volume":"12","author":"Kim","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e32232_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.oret.2018.04.018","article-title":"Systemic safety in ranibizumab-treated patients with neovascular age-related macular degeneration: a patient-level pooled analysis","volume":"2","author":"Zarbin","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.heliyon.2024.e32232_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bjophthalmol-2018-312453","article-title":"Safety of 5914 intravitreal ziv-aflibercept injections","volume":"103","author":"Singh","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.heliyon.2024.e32232_bib7","first-page":"375e381","article-title":"Serious AEs with bevacizumab or ranibizumab for age-related macular degeneration: meta-analysis of individual patient data","volume":"1","year":"2017","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32232_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198281","article-title":"Classification of healthy and diseased retina using SD-OCT imaging and Random Forest algorithm","volume":"13","author":"Hussain","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32232_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100259","article-title":"Radiomics-based assessment of OCT angiography images for diabetic retinopathy diagnosis","volume":"3","author":"Carrera-Escal\u00e9","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.heliyon.2024.e32232_bib10","article-title":"Multi-compartment spatially-derived radiomics from optical coherence tomography predict anti-VEGF treatment durability in macular edema secondary to retinal vascular disease: preliminary findings","volume":"9","author":"Sil","year":"2021","journal-title":"IEEE J Transl Eng Health Med"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32232_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100171","article-title":"OCT-derived radiomic features predict anti\u2013VEGF response and durability in neovascular age-related macular degeneration","volume":"2","author":"Kar","year":"2022","journal-title":"Ophthalmology Science"},{"key":"10.1016\/j.heliyon.2024.e32232_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/bjo.2008.138479","article-title":"Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin)","volume":"93","author":"Georgopoulos","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32232_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.oret.2021.05.003","article-title":"Clinical characteristics and outcomes of eyes with intraocular inflammation after brolucizumab: post hoc analysis of HAWK and HARRIER","volume":"6","author":"Singer","year":"2022","journal-title":"Ophthalmology Retina"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e32232_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259879","article-title":"Risk factors for emerging intraocular inflammation after intravitreal brolucizumab injection for age-related macular degeneration","volume":"16","author":"Mukai","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e32232_bib15","doi-asserted-by":"crossref","unstructured":"Arrigo, Alessandro MD; Aragona, Emanuela MD; Bandello, Francesco MD, FEBO. The role of inflammation in age-related macular degeneration: updates and possible therapeutic approaches. Asia-Pacific Journal of Ophthalmology:10.1097\/APO.0000000000000570, October 21, 2022. | DOI: 10.1097\/APO.0000000000000570.","DOI":"10.1097\/APO.0000000000000570"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32232_bib16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","article-title":"HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration","volume":"127","author":"Dugel","year":"2020","journal-title":"Ophthalmology"},{"issue":"29","key":"10.1016\/j.heliyon.2024.e32232_bib18","article-title":"Longitudinal higher-order OCT assessment of quantitative fluid dynamics and the total retinal fluid index in neovascular AMD","volume":"10","author":"Ehlers","year":"2021","journal-title":"Trans Vis Sci Tech."},{"key":"10.1016\/j.heliyon.2024.e32232_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.oret.2021.02.012","article-title":"Longitudinal assessment of ellipsoid zone integrity, subretinal hyperreflective material, and subretinal pigment epithelium disease in neovascular age-related macular degeneration","author":"Ehlers","year":"2021","journal-title":"Ophthalmology Retina"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e32232_bib19","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.oret.2019.06.010","article-title":"Higher-order assessment of OCT in diabetic macular edema from the VISTA study: ellipsoid zone dynamics and the retinal fluid index","volume":"3","author":"Ehlers","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32232_bib20","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1109\/TSMC.1973.4309314","article-title":"Textural features for image classification","volume":"SMC-3","author":"Haralick","year":"1973","journal-title":"IEEE Transactions on Systems, Man, and Cybernetics"},{"key":"10.1016\/j.heliyon.2024.e32232_bib21","series-title":"Textured Image Segmentation","author":"Laws","year":"1980"},{"key":"10.1016\/j.heliyon.2024.e32232_bib22","series-title":"1990 IEEE International Conference on Systems, Man, and Cybernetics Conference Proceedings, Los Angeles, CA, USA","first-page":"14","article-title":"Unsupervised texture segmentation using Gabor filters","author":"Jain","year":"1990"},{"issue":"22 Nov","key":"10.1016\/j.heliyon.2024.e32232_bib23","article-title":"Co-Occurrence of local anisotropic gradient orientations (CoLlAGe): a new radiomics descriptor","volume":"6","author":"Prasanna","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32232_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2307\/1412159","article-title":"The proof and measurement of association between two things","volume":"15","author":"Spearman","year":"1904","journal-title":"Am. J. Psychol."},{"key":"10.1016\/j.heliyon.2024.e32232_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. Roy. Stat. Soc. B"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32232_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9440(10)64525-7","article-title":"Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization","volume":"157","author":"Spilsbury","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32232_bib27","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s40123-020-00297-z","article-title":"Optical coherence tomography biomarkers of inflammation in diabetic macular edema treated by fluocinolone acetonide intravitreal drug-delivery system implant","volume":"9","author":"Arrigo","year":"2020","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.heliyon.2024.e32232_bib28","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.4103\/ijo.IJO_3156_20","article-title":"Subretinal hyperreflective material morphology in neovascular age-related macular degeneration: a case control study","volume":"69","author":"Alex","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.heliyon.2024.e32232_bib29","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/s41433-020-0799-y","article-title":"Association between visual acuity, lesion activity markers and retreatment decisions in neovascular age-related macular degeneration","volume":"34","author":"Chakravarthy","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.heliyon.2024.e32232_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/IAE.0000000000000690","article-title":"Predicting response of exudative age-related macular degeneration to Bevacizumab based on spectralis optical coherence tomography","volume":"36","author":"Segal","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.heliyon.2024.e32232_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/17469899.2020.1745062","article-title":"Hyperreflective material as a biomarker in neovascular age-related macular degeneration","volume":"15","author":"Casalino","year":"2020","journal-title":"Expet Rev. Ophthalmol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e32232_bib33","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.oret.2021.02.012","article-title":"Longitudinal assessment of ellipsoid zone integrity, subretinal hyperreflective material, and subretinal pigment epithelium disease in neovascular age-related macular degeneration","volume":"5","author":"Ehlers","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.heliyon.2024.e32232_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.594087","article-title":"Molecular biomarkers of neovascular age-related macular degeneration with incomplete response to anti-vascular endothelial growth factor treatment","volume":"11","author":"Mantel","year":"2020","journal-title":"Front. Pharmacol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402408263X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402408263X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:37:52Z","timestamp":1778884672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402408263X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":33,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S240584402408263X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32232","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optical coherence tomography-derived texture-based radiomics features identify eyes with intraocular inflammation in the HAWK clinical trial","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e32232"}}